It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2019.
2019 | Indore, Madhya Pradesh, India | ActiveOjal Pharmaceuticals Private Limited, a active private limited company, was established on 18 January 2019 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290MP2019PTC047557. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.86 M.
It upholds a compliant status. Its leadership includes Giriraj Gupta (Director), Anil Kumar Chopra (Director), Surbhi Gupta (Additional Director). Past directors included Atul Bapna. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ch-11, Kadambri Housing Board Colony, Silicon City, Rau Road, Indore, Madhya Pradesh, 452012.
U24290MP2019PTC047557
047557
18 January 2019
₹1.00 Cr
₹5.86 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Ojal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Giriraj Gupta | Director | 18 Jan 2019 | Current |
| Anil Kumar Chopra | Director | 27 Dec 2019 | Current |
| Surbhi Gupta | Additional Director | 26 Jul 2024 | Current |
| Kirti Shah | Additional Director | 26 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Apr 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ojal Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 57.17% increase. The company also saw a substantial improvement in profitability, with a 163.46% increase in profit. The company's net worth Soared by an impressive increase of 123.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Ojal Pharmaceuticals had a public holding of 11.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ojal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ojal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ojal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ojal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Surbhi Gupta was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Kirti Shah was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
The activity Ojal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
Anil Kumar Chopra was appointed as a Director was appointed as a Director on 27 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
The activity Giriraj Gupta was appointed as a Director was appointed as a Director on 18 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
The CIN of Ojal Pharmaceuticals Private Limited is U24290MP2019PTC047557.
Ojal Pharmaceuticals Private Limited is headquartered at Ch-11, Kadambri Housing Board Colony, Silicon City, Rau Road, Indore, Madhya Pradesh, 452012.
Ojal Pharmaceuticals Private Limited was incorporated on 18 January 2019.
The current directors of Ojal Pharmaceuticals Private Limited are
The primary industry of Ojal Pharmaceuticals Private Limited is Trade.
Ojal Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ojal Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹5.86 M.
The compliance status of Ojal Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX